Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin in Treatment of COVID-19
NCT04361422Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of isotretinoin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Tanta University. Primary endpoint: Clinical clearance. Status: unknown.
02
Drugs
isotretinoin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04361422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361422.